Genzyme planning 1,000 job cuts
September 14, 2010Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, job cuts
Genzyme has said it intends to cut back its workforce by around 1,000 over the next 15 months in order …
GSK launches global joint pain education programme
September 13, 2010Medical Communications chronic pain, disease awareness campaigns, osteoarthritis
GlaxoSmithKline has launched a global education programme to help sufferers from musculoskeletal conditions such as arthritis to self-manage pain in …
Zactima extends progression free survival in other thyroid cancers
September 13, 2010Research and Development thyroid cancer, zactima
New data suggests patients with the more common forms of thyroid cancer respond to AstraZeneca’s Zactima. The drug has already …
NICE won’t approve Abilify without more data
September 13, 2010Sales and Marketing Abilify, BMS, NICE
NICE is unlikely to approve Bristol-Myers Squibb’s schizophrenia drug Abilify unless the company can provide more data on its clinical …
Countdown to Launch
September 13, 2010Sales and Marketing marketing, product launch
When NASA launches a rocket, most of the hard work is already done. The flight itself is relatively short, yet …
BMS appoints UK market access director
September 13, 2010Sales and Marketing BMS, UK, appointment, sales and marketing
Patrick Hopkinson has joined Bristol-Myers Squibb as director of market access and external affairs in the UK. He joins the …
AZ signs cancer development deal
September 13, 2010Research and Development AstraZeneca, CRT, Cancer Research UK
AstraZeneca has agreed a deal with charity Cancer Research UK to develop a first-in-class cancer treatment. AZD-3965 targets the monocarboxylate …
Sanofi readies cancer drugs’ coms support
September 10, 2010Medical Communications just health pr
Sanofi-Aventis is readying communications support for two cancer drugs in its portfolio. The pharma company has handed UK communications for …
Merck plans jobs cuts in Ireland
September 10, 2010Manufacturing and Production Ireland, Merck & Co, Schering-Plough, job cuts
A manufacturing plant in Ireland is the latest to face staff cuts in the wake of Merck & Co’s merger …
Transgene acquires rights to cancer vaccine
September 10, 2010Research and Development JX-594, Jennerex, Transgene, cancer vaccine
French biotech company Transgene has acquired rights to commercialise a novel cancer vaccine that is being tested against multiple types …
Low dose Victoza on track for NICE approval
September 10, 2010Sales and Marketing NICE, Novo Nordisk, Victoza
Novo Nordisk is on track to receive NICE approval for its type II diabetes drug Victoza, but will still have …
Adventis Health adds new recruits
September 10, 2010Medical Communications Adventis, appointment, medical communications
Beaconsfield, UK-based healthcare communications agency Adventis Health has added two more recruits to its multi-disciplinary teams. Dan Blomfield (pictured left), …
GSK paves way for biopharmaceuticals growth
September 9, 2010Research and Development GlaxoSmithKline, Lonza, biologics
GlaxoSmithKline has handed Swiss contract manufacturer Lonza a contract to produce clinical trial batches of five monoclonal antibodies that are …
Universities attack European research grant
September 9, 2010Research and Development EFPIA, IMI, Innovative Medicines Initiative, academia
A European initiative aimed at fostering new medical research is neglecting its public partners in favour of its private ones, …
EU set to pass stricter laws for experiments on animals
September 9, 2010Research and Development Animal testing, Animal tests
The number of animals used in scientific experiments will be reduced under new EU legislation agreed by the European Parliament …
Tzvi Palash joins Protalix BioTherapeutics
September 9, 2010Manufacturing and Production, Research and Development Portalix BioTherapeutics, appointment, manufacturing and production, research and development
Protalix BioTherapeutics has appointed Tzvi Palash to the newly-created position of chief operating officer. He will be responsible for overseeing …
J&J and Merck heading for showdown over drug rights
September 8, 2010Sales and Marketing Johnson & Johnson, Merck, Remicade
Johnson & Johnson’s disagreement with Merck over rights to two arthritis drugs is set to come to a head in …
inVentiv Health acquires French advertising group
September 8, 2010Medical Communications France, advertising, inVentiv Health
InVentiv Health is to acquire Star Terre Santé, a leading group of healthcare marketing and communications agencies based in Paris. …
Pharma sector optimism growing
September 8, 2010Sales and Marketing Eversheds, economic climate
Pharma execs are more confident about the sector’s outlook than they were at the start of the year. A survey …
Greece to cut 4,000 drug prices by a fifth
September 8, 2010Sales and Marketing Greece, economic climate, price cuts, pricing & Reimbursement
The Greek government has released a list of over 4,000 drugs on which it will impose heavy price cuts. This …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
